iBio (IBIO) News Today $0.60 -0.03 (-4.48%) As of 08/6/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesInsider TradesSEC FilingsBuy This Stock IBIO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Unboxing Iron Man Mark 42 — ZD Toys 1:10 Luminous Action Figure (Part 2)July 8, 2025 | msn.comInsider Buyers At iBio Likely Disappointed With 23% SlideMay 11, 2025 | finance.yahoo.comiBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing ...April 9, 2025 | seekingalpha.comiBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025April 1, 2025 | msn.comPharos iBio Co. Ltd.March 24, 2025 | wsj.comiBio files to sell 246K shares of common stock for holdersJanuary 31, 2025 | markets.businessinsider.comiBio Announces New Investments from Board Members and OfficersJanuary 13, 2025 | markets.businessinsider.comiBio expands cardiometabolic, obesity treatment development programJanuary 3, 2025 | markets.businessinsider.comiBio Strengthens Board with Appointment of Two New Independent DirectorsNovember 25, 2024 | finance.yahoo.comOklo Inc. Reports Q3 2024 Financial ResultsNovember 15, 2024 | markets.businessinsider.comiBio Inc. stock remains steady Monday, underperforms marketNovember 11, 2024 | marketwatch.comOhio Senate Results: Bernie Moreno WinsNovember 6, 2024 | nbcnews.comiBio Inc. stock remains steady Monday, still outperforms marketNovember 4, 2024 | marketwatch.comBiopharmaceuticals Contract Manufacturing Industry Research 2024-2030: Biopharma Giants Increasingly Outsource to Streamline Drug DevelopmentsOctober 14, 2024 | uk.finance.yahoo.comWhat channel is Oregon vs. Ohio State on today? Time, TV schedule to watch week 7 gameOctober 12, 2024 | msn.comHow to watch Ohio State vs Oregon college football: TV, Live stream info, kickoff time, game previewOctober 12, 2024 | msn.comStock Market Today: Dow Rises; Chinese Indexes Post Best Week in YearsSeptember 27, 2024 | wsj.comiBio, Inc.: iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate UpdateSeptember 21, 2024 | finanznachrichten.deiBio Inc. stock outperforms market despite losses on the daySeptember 16, 2024 | marketwatch.comStock market today: Dow jumps 484 points as US stocks rebound ahead of key inflation reportSeptember 10, 2024 | msn.comInovio Pharmaceuticals, Inc. (INO)August 29, 2024 | finance.yahoo.comiBio Inc. stock remains steady Wednesday, still outperforms marketAugust 28, 2024 | marketwatch.com13F Recap Q2 2024: Klarman, Rosenstein, Miller And MoreAugust 25, 2024 | msn.comiBio Inc. stock rises Friday, still underperforms marketAugust 23, 2024 | marketwatch.comCOSCIENS BIOPHARMA CORP. (ET8.F)August 22, 2024 | finance.yahoo.comiBio Inc. stock remains steady Tuesday, still outperforms marketAugust 20, 2024 | marketwatch.comiBio Inc. stock remains steady Thursday, underperforms marketAugust 15, 2024 | marketwatch.com0JV0.SG,0P00013BY9,0 (0JV0.SG)August 15, 2024 | nz.finance.yahoo.comOptimistic Outlook for ProQR: Solid Financials and Promising Drug Pipeline Justify Buy RatingAugust 9, 2024 | markets.businessinsider.comiBio Inc. stock falls Friday, underperforms marketAugust 2, 2024 | marketwatch.comBuy Rating Justified by Arbutus Biopharma’s Strong Financials and Focused Clinical StrategyAugust 2, 2024 | markets.businessinsider.comTesla’s latest earnings expose chronically weak profitability and an inflated share priceJuly 25, 2024 | msn.comTesla's 2Q Profit Falls 45% to $1.48 Billion as Sales Drop Despite Price Cuts and Low-Interest LoansJuly 25, 2024 | usnews.comiBio, Mesoblast, Kodiak Sciences among healthcare moversMarch 28, 2024 | msn.comMicro-Cap Stock iBio Doubles On Wednesday - Here's WhyMarch 27, 2024 | msn.comiBio partners with AstralBio to develop obesity treatments using AI-driven platformMarch 27, 2024 | proactiveinvestors.comiBio Shares Double After Collaboration Agreement With AstralBioMarch 27, 2024 | marketwatch.comWhy Is iBio (IBIO) Stock Up 125% Today?March 27, 2024 | investorplace.comMega Millions winning numbers for enormous $1.1 billion jackpot on March 26March 27, 2024 | msn.comRon DeSantis signs bill banning social media for kids under 14 in FloridaMarch 27, 2024 | msn.comiBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic DiseasesMarch 27, 2024 | globenewswire.comiBio Announces $15.0 Million Private PlacementMarch 26, 2024 | globenewswire.comiBio Sells Preclinical PD-1 Antagonist Antibody Program to OtsukaFebruary 26, 2024 | marketwatch.comiBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to OtsukaFebruary 26, 2024 | globenewswire.comiBio IncFebruary 22, 2024 | money.usnews.comHow to capture screenshots on your Mac: A step-by-step guideFebruary 12, 2024 | msn.comTrain hits, kills person who trespassed on tracks in HaywardFebruary 12, 2024 | msn.comUsher's Wife Responds To Alicia Keys Super Bowl DramaFebruary 12, 2024 | msn.comiBio Announces Participation in 23rd Annual PepTalk ConferenceJanuary 16, 2024 | finance.yahoo.comiBio Amends and Extends Maturity of Credit AgreementDecember 26, 2023 | finance.yahoo.com Get iBio News Delivered to You Automatically Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address IBIO Media Mentions By Week IBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IBIO News Sentiment▼0.000.42▲Average Medical News Sentiment IBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IBIO Articles This Week▼00▲IBIO Articles Average Week Get iBio News Delivered to You Automatically Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ELYM News Today JSPR News Today AADI News Today HYPD News Today RNXT News Today CVM News Today LTRN News Today XCUR News Today ACRV News Today PLUR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEMKT:IBIO) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
